BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,503,604 | +3765.0% | 251,818 | +4565.9% | 0.03% | +933.3% |
| Q2 2023 | $245,890 | +16.3% | 5,397 | +3.5% | 0.00% | +50.0% |
| Q1 2023 | $211,434 | -97.0% | 5,213 | -95.3% | 0.00% | -98.0% |
| Q2 2022 | $7,156,000 | +2785.5% | 109,788 | +3525.8% | 0.10% | +2400.0% |
| Q3 2021 | $248,000 | +1.2% | 3,028 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $245,000 | -3.5% | 3,018 | +1.0% | 0.00% | -20.0% |
| Q1 2021 | $254,000 | +2.4% | 2,987 | -3.6% | 0.01% | -16.7% |
| Q4 2020 | $248,000 | -90.7% | 3,099 | -90.8% | 0.01% | -91.4% |
| Q3 2020 | $2,679,000 | -0.1% | 33,643 | +11.9% | 0.07% | -9.1% |
| Q2 2020 | $2,681,000 | -43.3% | 30,060 | -42.1% | 0.08% | -54.4% |
| Q1 2020 | $4,725,000 | +150.4% | 51,923 | +136.6% | 0.17% | +103.6% |
| Q2 2019 | $1,887,000 | +109.2% | 21,947 | +59.9% | 0.08% | +36.1% |
| Q1 2018 | $902,000 | -2.3% | 13,722 | -6.5% | 0.06% | -19.7% |
| Q3 2017 | $923,000 | +39.0% | 14,679 | +5.9% | 0.08% | -23.2% |
| Q3 2016 | $664,000 | – | 13,866 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |